The abstract shows TYROBP deficiency is neuroprotective despite being required for TREM2, CD33, and CR3 function - receptors associated with AD risk. This counterintuitive finding challenges current understanding of how these immune receptors contribute to AD pathogenesis. Gap type: contradiction Source paper: Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer's pathology. (None, None, PMID:28612290)
Landscape Summary: Why is TYROBP deficiency neuroprotective when TYROBP is an adapter for multiple AD risk receptors? is a 0.89 priority gap in neuroinflammation. It has 0 linked hypotheses with average composite score 0.000. Status: partially_addressed.
Colonna, Sevlever, et al. (TREM2 biology)
Why is TYROBP deficiency neuroprotective when TYROBP is an adapter for multiple AD risk receptors? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: